Colorectal Cancer chemotherapy protocols and prescriptions
Blank Chemotherapy Prescriptions
Included are blank chemocare regimen specific prescription files to be used as a part of local Trust contingency plan if the Chemocare Network Systems are not available. Network Chemocare Blank Colorectal Cancer Prescription templates zip folder click here. Last updated 20.12.2017.
Chemotherapy Protocols
The documents below are Northern Cancer Alliance (NCA) approved protocols for the management of patients receiving chemotherapy for Colorectal Cancers. All prescribing, preparation, dispensing and administration of chemotherapy should be within a framework of safe practice.
DISCLAIMER: The protocols on this website are for local guidance only, their accuracy cannot be guaranteed, please refer the SPC for information on the individual products. There are a number of protocols that are past their expiry/ review date. These are retained on the website for information only following requests from local Trusts, they must only be used on the understanding the responsibility for the use lies with local organisation and not NCA. NCA cannot accept responsibility for the validity of content of any documents that are past the review date.
| No | Regime Name | Valid Until | Protocol |
|---|---|---|---|
| CR001 | FOLFIRI | March 2021 | Download |
| CR002 | Weekly Irinotecan | March 2021 | Download |
| CR003 | Irinotecan three weekly | March 2021 | Download |
| CR004 | Weekly 5FU and Folinic acid | March 2021 | Download |
| CR005 | MAYO 5FU and Folinic acid | March 2021 | Download |
| CR006 | Mod DeGramont | March 2021 | Download |
| CR007 | FOLFOX | March 2021 | Download |
| CR008 | CAPOX (Capecitabine & Oxaliplatin) | March 2021 | Download |
| CR009 | Capecitabine | March 2021 | Download |
| CR010 | Lokitch (7 day fluouracil) | March 2021 | Download |
| CR012 | Raltitrexed | March 2021 | Download |
| CR017 | CAPIRI (Capecitabine & Irinotecan) | March 2021 | Download |
| CR018 | Capecitabine with radiotherapy | March 2021 | Download |
| CR019 | Lonsurf (Trifluridine–tipiracil) | August 2019 | Download |
| CR028 | Cetuximab with FOLFIRI | March 2021 | Download |
| CR030 | Cetuximab with FOLFOX | March 2021 | Download |
| CR031 | Panitumumab + FOLFIRI (1st line) | March 2021 | Download |
| CR032 | Panitumumab + FOLFOX (1st line) | March 2021 | Download |
| Discontinued documents | |||
| CR011 | UFToral | May 2016 | |
| CR013 | Combat (Mitomycin & Fluouracil) | Feb 2016 | |
| NCDF | Bevacizumab with Capecitabine | Feb 2016 | |
| NCDF | Bevacizumab and FOLFOX | Feb 2016 | |
| NCDF | Bevacizumab and FOLFIRI | Feb 2016 | |
| NCDF | Bevacizumab and De Gramont | Feb 2016 | |
| NCDF | Bevacizumab and XELOX | Feb 2016 | |
| NCDF | Bevacizumab and XELIRI | Feb 2016 | |
| NCDF | 2 weekly Cetuximab with Irinotecan | Apr 2016 | |
| NCDF | Single Agent Cetuximab (3rd Line) | Apr 2016 | |
| NCDF | Cetuximab with DeGramont (1st line) | Apr 2016 | |
| NCDF | Aflibercept | Feb 201 | |